Wang, Chao
Shi, Yunping
Liu, Yang
Zhou, Ying
Du, Jing
Hu, Xiao
Li, Wei
Li, Jiaze
Gao, Yanlin
Li, Gang
Funding for this research was provided by:
the Special Fund for Health Development Research of Beijing (2024-2G-30121)
the High-level Public Health Talent Development Program of Beijing (Discipline Backbone-02-12, Discipline Leader-01-09)
National Key Research and Development Program of China (2023YFC2308703)
Article History
Received: 20 November 2024
Accepted: 9 April 2025
First Online: 23 April 2025
Declarations
:
: This study is based on non-anonymized data from the infectious disease reporting system, but there are no conflicts of interest between any of the authors and the individuals in the data and only the data analysts have access to the non-anonymized data. The study has been approved by the Ethics Committee (Ethical Review Committee of the Beijing Center for Disease Prevention and Control, ethical approval notification number: 2023D []. In accordance with the provisions of the 'Infectious Disease Law of the People's Republic of China' and the 'Infectious Disease Reporting Management Regulations', the requirement for informed consent was waived for this study.The study was conducted in compliance with the ethical principles outlined in the Declaration of Helsinki. Specifically, the research was designed and conducted to respect the rights, dignity, and well-being of the participants, and the waiver of informed consent was justified given the nature of the data and the regulatory framework governing infectious disease reporting. The study also adhered to the principles of minimizing harm and ensuring the confidentiality of personal information.
: Not applicable.
: The authors declare no competing interests.